The US Food and Drug Administration on Wednesday authorized the Novavax COVID-19 vaccine for adults 18 and older. Novavax is a two-dose primary series vaccine, with each dose given three weeks apart. Because it's authorized as a primary series vaccine, ...
VIEW MORE : https://bit.ly/1breakingnews
